Clinical Trial Update: Study to Assess OPB-31121 in Advanced Leukemias or Myelodysplastic Syndromes [Phase 1]

View source ↗

Summary

Phase 1 trial update showing termination of the study evaluating OPB-31121 in advanced leukemias and myelodysplastic syndromes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• OPB-31121 (OPB-31121)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Leukemia | Phase 1 | Status: TERMINATED